Vijaya Diagnostic Centre Share Price Today: Why VIJAYA Is Rising 4.08% | 20 November 2026

NSE: VIJAYA · 20 November 2026

Price
₹1,572.30
Change
+4.08%
High / Low
₹1,587.00 / ₹1,500.30
Prev. Close
₹1,510.60
Volume
5.38 lakh
Price as of
20 November 2026 · 03:30 PM IST
Key Takeaways
  • Vijaya Diagnostic Centre Ltd. (VIJAYA) advanced 4.08% today, closing at ₹1572.30 after touching an intraday high of ₹1587.00 and a low of ₹1500.30 from a previous close of ₹1510.60.
  • Vijaya Diagnostic Centre Limited submitted its financial results and investor presentation for the period ended September 30, 2026, highlighting continued revenue and operating income expansion across its diagnostic network. Management subsequently hosted an earnings conference call with institutional investors on November 04, 2026, to discuss operational metrics and business growth.
  • Trading volume was 2.96 times the 20-day average daily volume.

Why is Vijaya Diagnostic Centre share price rising on 20 November 2026?

Vijaya Diagnostic Centre Ltd. (VIJAYA) advanced 4.08% today, closing at ₹1572.30 after touching an intraday high of ₹1587.00 and a low of ₹1500.30 from a previous close of ₹1510.60.

The broader market and sector benchmarks reflected positive momentum, with the Nifty rising 1.12% and the Nifty Pharma sector gaining 0.61%. The stock's outperformance relative to the sectoral benchmark coincides with a broader recovery following a 5-day return of 11.50% and a 20-day return of 13.05%.

While no same-day operational announcement or earnings filing was released, the stock's recent price action follows ongoing institutional engagement, including a scheduled institutional investor meeting hosted by Investec Confluence on November 18, 2026, alongside its Q2 FY27 financial performance reported in early November 2026.

5.38 lakh shares traded by 20 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 1.82 lakh shares (2.96 times). The five-day average daily volume was 3.34 lakh shares. Separately, the NSE report for 20 November 2026 showed 89,143 shares delivered, representing 16.55% of that day’s traded volume. The same report recorded 40,756 trades.

Likely Reason
Strong volume-backed participation and positive sector momentum

The stock moved higher alongside broader healthcare sector gains, supported by significantly elevated trading volumes at nearly 3 times its 20-day average. No single direct catalyst occurred today to explicitly trigger the move.

Latest Company Developments

Q2 FY2027 Financial Results Reported
3 November 2026

Vijaya Diagnostic Centre Limited submitted its financial results and investor presentation for the period ended September 30, 2026, highlighting continued revenue and operating income expansion across its diagnostic network. Management subsequently hosted an earnings conference call with institutional investors on November 04, 2026, to discuss operational metrics and business growth.

Quarterly earnings updates provide baseline visibility into the company's financial health, margins, and diagnostic volume growth across core markets.

Acquisition of Arya Wellness Centre Business
11 September 2026

The company approved the execution of a Business Transfer Agreement for the 100% acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. This transaction marks an ongoing inorganic expansion strategy into underserved regional markets outside its core southern footprint.

Inorganic expansions highlight management's growth vector through regional network scaling and increased geographic diversification.

Earnings / operating update
4 November 2026

a press release dated November 03, 2026, titled "Press Release on Q2 FY2027 Results".

Investment / acquisition update
12 September 2026

General Updates – Investor Presentation – 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.

Ownership & Transaction Activity

Shareholding
As of 30 September 2026
Promoter holding
52.46%
52.51% on 30 June 2026
FII/FPI
10.66%
11.66% on 30 June 2026
Institutional holding
43.16%
43.27% on 30 June 2026

Mutual Fund Holdings

Mutual-fund ownership

Mutual funds held 31.44% on 30 September 2026. This compares with 30.66% on 30 June 2026, a change of +0.78 percentage points.

The filing reported 27 MF/UTI holders.

KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK BUSINESS C
30 September 2026
67.84 lakh shares · 6.59%
HDFC MUTUAL FUND – HDFC CHILDRENS FUND
30 September 2026
57.38 lakh shares · 5.57%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA MUL
30 September 2026
46.67 lakh shares · 4.53%
These are quarterly holdings, rather than purchases or sales on the article date.

What to Watch Next

  • Execution progress and revenue integration of the Arya Wellness Centre acquisition in Guwahati
  • Sustained delivery volume relative to the 16.55% recorded today
  • Institutional participation trends following recent analyst interactions
  • Quarterly footfall trends across pathology and radiology segments

Other Dated Coverage

More Vijaya Diagnostic Centre news and dated analysis →

Frequently Asked Questions

What is the latest Vijaya Diagnostic Centre company news?

Vijaya Diagnostic Centre Limited submitted its financial results and investor presentation for the period ended September 30, 2026, highlighting continued revenue and operating income expansion across its diagnostic network. Management subsequently hosted an earnings conference call with institutional investors on November 04, 2026, to discuss operational metrics and business growth.

How strong was Vijaya Diagnostic Centre’s trading volume?

5.38 lakh shares traded, 2.96 times the 20-day average daily volume. The price and volume data are dated 20 November 2026 · 03:30 PM IST.

Do the mutual-fund figures show buying today?

They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.

Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst

Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top